CDEK
← All organizations

Adamas Pharmaceuticals, Inc.

For profitWebsite ↗

Also known as: Adamas Biotech S.r.l. | ADAMAS OPERATIONS | ADAMAS PHARMA | Adamas Pharmaceuticals | Adamas Pharmaceuticals, Inc.

Phase 1Phase 2Phase 3Phase 4

Highest phase reached

Phase 4

First clinical trial

Sep 1, 2009

First marketed drug

Aug 24, 2017

Last known activity

Jul 30, 2025

Acquired by Supernus Pharmaceuticals on Oct 11, 2021

Timeline

2000s

  1. Jul 1, 2000

    Adamas Pharmaceuticals, Inc.— Founded

2010s

  1. Aug 24, 2017

    amantadine— Marketing Organization

  2. Aug 24, 2017

    amantadine— NDA Secondary Org

2020s

  1. Oct 11, 2021

    Supernus Pharmaceuticals— Acquired By

Drugs by trial phase (3 distinct, 10 trials)

Phase 4 (1 own, 0 via acquisition)

Phase 2 (1 own, 0 via acquisition)

Other trials (1 own, 0 via acquisition)

Indications

Studied for

Marketed drugs (1)

Recent trials (16)

Details

Founded
Emeryville, CA, US Jul 1, 2000
Last known activity
Jul 30, 2025